Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
Targeted serum metabolomics (CHRIS baseline)
x0pt126
PC ae C30:2
Phosphatidylcholine acyl-alkyl C30:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt127
PC ae C32:1
Phosphatidylcholine acyl-alkyl C32:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt128
PC ae C32:2
Phosphatidylcholine acyl-alkyl C32:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt129
PC ae C34:0
Phosphatidylcholine acyl-alkyl C34:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt130
PC ae C34:1
Phosphatidylcholine acyl-alkyl C34:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt131
PC ae C34:2
Phosphatidylcholine acyl-alkyl C34:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt132
PC ae C34:3
Phosphatidylcholine acyl-alkyl C34:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt133
PC ae C36:0
Phosphatidylcholine acyl-alkyl C36:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt134
PC ae C36:1
Phosphatidylcholine acyl-alkyl C36:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt135
PC ae C36:2
Phosphatidylcholine acyl-alkyl C36:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt136
PC ae C36:3
Phosphatidylcholine acyl-alkyl C36:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt137
PC ae C36:4
Phosphatidylcholine acyl-alkyl C36:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt138
PC ae C36:5
Phosphatidylcholine acyl-alkyl C36:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt139
PC ae C38:0
Phosphatidylcholine acyl-alkyl C38:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt140
PC ae C38:1
Phosphatidylcholine acyl-alkyl C38:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt141
PC ae C38:2
Phosphatidylcholine acyl-alkyl C38:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt142
PC ae C38:3
Phosphatidylcholine acyl-alkyl C38:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt143
PC ae C38:4
Phosphatidylcholine acyl-alkyl C38:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt144
PC ae C38:5
Phosphatidylcholine acyl-alkyl C38:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt145
PC ae C38:6
Phosphatidylcholine acyl-alkyl C38:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt146
PC ae C40:1
Phosphatidylcholine acyl-alkyl C40:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt147
PC ae C40:2
Phosphatidylcholine acyl-alkyl C40:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt148
PC ae C40:3
Phosphatidylcholine acyl-alkyl C40:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt149
PC ae C40:4
Phosphatidylcholine acyl-alkyl C40:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt150
PC ae C40:5
Phosphatidylcholine acyl-alkyl C40:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt151
PC ae C40:6
Phosphatidylcholine acyl-alkyl C40:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt152
PC ae C42:0
Phosphatidylcholine acyl-alkyl C42:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt153
PC ae C42:1
Phosphatidylcholine acyl-alkyl C42:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt154
PC ae C42:2
Phosphatidylcholine acyl-alkyl C42:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt155
PC ae C42:3
Phosphatidylcholine acyl-alkyl C42:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt156
PC ae C42:4
Phosphatidylcholine acyl-alkyl C42:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt157
PC ae C42:5
Phosphatidylcholine acyl-alkyl C42:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt158
PC ae C44:3
Phosphatidylcholine acyl-alkyl C44:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt159
PC ae C44:4
Phosphatidylcholine acyl-alkyl C44:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt160
PC ae C44:5
Phosphatidylcholine acyl-alkyl C44:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt161
PC ae C44:6
Phosphatidylcholine acyl-alkyl C44:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt162
SM (OH) C14:1
Hydroxysphingomyeline C14:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt163
SM (OH) C16:1
Hydroxysphingomyeline C16:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt164
SM (OH) C22:1
Hydroxysphingomyeline C22:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt165
SM (OH) C22:2
Hydroxysphingomyeline C22:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt166
SM (OH) C24:1
Hydroxysphingomyeline C24:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt167
SM C16:0
Sphingomyeline C16:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt168
SM C16:1
Sphingomyeline C16:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt169
SM C18:0
Sphingomyeline C18:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt170
SM C18:1
Sphingomyeline C18:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt171
SM C20:2
Sphingomyeline C20:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt172
SM C24:0
Sphingomyeline C24:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt173
SM C24:1
Sphingomyeline C24:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt174
SM C26:0
Sphingomyeline C26:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt175
SM C26:1
Sphingomyeline C26:1
Float
Restless Legs Syndrome (CHRIS baseline)
x0rd08
RLS duration (years)
RLS-D duration
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0re01
Respiratory Sinus Arrhythmia (RSA) (filtered)
Respiratory Sinus Arrhythmia (RSA) (filtered)
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0re02
Respiratory Sinus Arrhythmia (RSA) (open)
Respiratory Sinus Arrhythmia (RSA) (open)
Float
Smoking (CHRIS baseline)
x0sm06d
Interruption duration cigarette smoking, v.1
Interruption duration cigarette smoking, v.1
Float
Smoking (CHRIS baseline)
x0sm35
Smoking: Cigarettes (current)
How much do you now smoke on average? No. of Cigarettes/day (current)
Float
Smoking (CHRIS baseline)
x0sm39d
Interruption duration cigarette smoking, v. 2-3
Interruption duration cigarette smoking, v. 2-3
Float
Smoking (CHRIS baseline)
x0sm44
Smoking: Pipe tobacco (past)
On average of the entire time you smoked, before you stopped or cut down, how much did you smoke? Pipe tobacco in grams/week (in the past)
Float
Smoking (CHRIS baseline)
x0sm49
Passive smoking: Total
How many hours per day are you exposed to other people's smoke? (hours/day)
Float
Smoking (CHRIS baseline)
x0sm49a
Passive smoking: At home
How many hours per day, are you exposed to other people’s tobacco smoke in the following locations? At home (hours/day)
Float
Smoking (CHRIS baseline)
x0sm49b
Passive smoking: At workplace
How many hours per day, are you exposed to other people’s tobacco smoke in the following locations? At workplace (hours/day)
Float
Smoking (CHRIS baseline)
x0sm49c
Passive smoking: In bars/restaurants/cinemas
How many hours per day, are you exposed to other people’s tobacco smoke in the following locations? In bars/restaurants/cinemas (hours/day)
Float
Smoking (CHRIS baseline)
x0sm49d
Passive smoking: Elsewhere
How many hours per day, are you exposed to other people’s tobacco smoke in the following locations? Elsewhere (hours/day)
Float
Smoking (CHRIS baseline)
x0sm52
Cigarettes smoking lifetime pack-years
Cigarettes smoking lifetime pack-years
Float
Smoking (CHRIS baseline)
x0sm53
Cigars smoking lifetime pack-years
Cigars smoking lifetime pack-years
Float
Smoking (CHRIS baseline)
x0sm54
Pipe smoking lifetime pack-years
Pipe smoking lifetime pack-years
Float
Smoking (CHRIS baseline)
x0sm55
Lifetime pack-years
All smoking lifetime pack-years
Float
Smoking (CHRIS baseline)
x0sm57
Tobacco (current)
Tobacco grams/day (current)
Float
Smoking (CHRIS baseline)
x0sm58
Tobacco (past)
Tobacco grams/day (past)
Float
Smoking (CHRIS baseline)
x0sm59
Cumulative pack-years (current)
Cumulative pack-years (current)
Float
Smoking (CHRIS baseline)
x0sm60
Cumulative pack-years (past)
Cumulative pack-years (past)
Float
Smoking (CHRIS baseline)
x0sm61
Tobacco (current, all tobacco sources)
Total smoking grams/day (current, all tobacco sources)
Float
Sleep quality (CHRIS baseline)
x0sq04a
4. During the past month, how many hours of actual sleep did you get at night?
During the past month, how many hours of actual sleep did you get at night? (This may be different than the number of hours you spent in bed.)
Float
Gynecology (CHRIS baseline)
x0wo01b
Menarche
How old were you at your first menstruation (menarche)?
Float
Gynecology (CHRIS baseline)
x0wo04b
Use of contraceptive pills
How many months or years have you taken contraceptives?
Float
Gynecology (CHRIS baseline)
x0wo11a
Hormone replacement preparations
How many years have you taken these hormone preparations all together?
Float
Biochemical traits (CHRIS COVID-19)
cc_examd
Date of sample collection
Date of sample collection
Date
Baseline information (CHRIS COVID-19)
ccbqdate
Submission date of CC19 baseline questionnaire
Submission date of CHRIS COVID-19 baseline questionnaire
Date
Longitudinal information (CHRIS COVID-19)
cclq07
Date of first symptom appearance
On approximately which date did the first symptoms appear?
Date
Longitudinal information (CHRIS COVID-19)
cclq17a
Date first Covid-19 vaccination
When did you receive the first dose of vaccine?
Date
Longitudinal information (CHRIS COVID-19)
cclq17b
Date last Covid-19 vaccination
When did you receive the last dose of vaccine? (same date as first dose in case of single dose vaccines)
Date
Longitudinal information (CHRIS COVID-19)
cclqdate
Submission date of CC19 questionnaire
Submission date of CHRIS COVID-19 questionnaire
Date
Longitudinal information (CHRIS COVID-19)
cclqldate
Date of last CC19 questionnaire
Date of last CHRIS COVID-19 questionnaire
Date
Vaccination status (CHRIS COVID-19)
ccva22
Date of SARS-CoV-2 vaccination
Date of SARS-CoV-2 vaccination
Date
Vaccination status (CHRIS COVID-19)
ccvadate
Date of SARS-CoV-2 vaccination status assessment
Date of SARS-CoV-2 vaccination status assessment
Date
Movement disorder examination (CHRIS baseline)
x0_examddp
Date of participation
Date of participation at Movement Disorder Deep Phenotyping
Date
Complement system (CHRIS baseline)
x0cs05
Date of the experiment
Date of the experiment
Date
Mitochondrial DNA copy number (CHRIS baseline)
x0mt06
Date of experiment
Date of experiment
Date
Mitochondrial DNA copy number (CHRIS baseline)
x0mt06a
Date of experiment (2nd measurement)
Date of experiment (2nd measurement)
Date
General information (CHRIS COVID-19)
cc_hhid
Identifier for individuals belonging to the same household
Identifier for individuals belonging to the same household
Character
Participation information (CHRIS baseline)
x0_note2
Participation notes elaborated
Translated and cleaned general notes regarding participation
Character
Participation information (CHRIS baseline)
x0_noteint2
Notes interview elaborated
Translated and cleaned notes regarding the completion of the interview-based questionnaire elaborated
Character
Participation information (CHRIS baseline)
x0_notesaliva
Notes saliva collection
Notes regarding the completion of the saliva collection
Character
Participation information (CHRIS baseline)
x0_noteself
Notes self-admin
Notes regarding the completion of the self-administered questionnaires
Character
Participation information (CHRIS baseline)
x0_notespiro
Notes spiralography
Notes regarding the completion of the spiralography
Character
Movement disorder examination (CHRIS baseline)
x0_workfdp
Work flow (A-M)
Work flow for Movement Disorder Deep Phenotyping (A-M)
Character
Cardiac arrhythmias (CHRIS baseline)
x0af03i
Atrial fibrillation: Symptoms (other/free text)
Describe the other discomfort
Character
Cardiac arrhythmias (CHRIS baseline)
x0af07c2
Type of cardiac arrhythmia, elaborated (free text)
Describe the type of cardiac arrhythmia (elaborated)
Character
Cardiac arrhythmias (CHRIS baseline)
x0afn1b
Cardiac arrhythmia notes elaborated (atrial fibrillation)
Cardiac arrhythmia notes elaborated (atrial fibrillation)
Character
Cardiac arrhythmias (CHRIS baseline)
x0afn2b
Cardiac arrhythmia notes elaborated (symptoms)
Cardiac arrhythmia notes elaborated (symptoms)
Character
Cardiac arrhythmias (CHRIS baseline)
x0afn3b
Cardiac arrhythmia notes elaborated (chronic)
Cardiac arrhythmia notes elaborated (chronic)
Character
Previous
1
13
14
15
16
17
43
Next